O‘PKA SARATONIDA KIMYOTERAPIYA SAMARADORLIGINI OSHIRISH YO‘LLARI
Аннотация
O‘pka saratoni zamonaviy tibbiyotning eng murakkab va dolzarb muammolaridan biridir. Ko‘pchilik hollarda bemorlar kasallikning kech bosqichida murojaat qilgani sababli kimyoterapiya samaradorligi pasayadi va yashash prognozi yomonlashadi.[1] An’anaviy sitotoksik terapiya ba’zi hollarda rezistentlik yuzaga kelishi sababli o‘smalarga yetarli ta’sir ko‘rsatmaydi. Shu bois, kimyoterapiya samaradorligini oshirishga qaratilgan individual yondashuvlar va yangi strategiyalarni aniqlash dolzarb ahamiyatga ega.[2]
Библиографические ссылки
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594.
Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454.
Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377:849–861.
Загрузки
Опубликован
Выпуск
Раздел
Как цитировать
